According to Immunome's latest financial reports the company's current EPS (TTM) is -$3.47. In 2022 the company made an earnings per share (EPS) of -$4.88 a decrease over its 2021 EPS that were of -$3.36.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.31 | -32.16% |
2022 | -$4.88 | 45.07% |
2021 | -$3.36 | 3.38% |
2020 | -$3.25 |